Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Hem Onc News: Chemo-free treatment of mesothelioma, FDA approves liquid biopsy for NSCLC, and swallowable device for esophageal cancer

    Hem Onc News: Chemo-free treatment of mesothelioma, FDA approves liquid biopsy for NSCLC, and swallowable device for esophageal cancer

    FromBlood & Cancer

    Start listeningView podcast show

    Hem Onc News: Chemo-free treatment of mesothelioma, FDA approves liquid biopsy for NSCLC, and swallowable device for esophageal cancer

    FromBlood & Cancer

    ratings:
    Length:
    14 minutes
    Released:
    Aug 18, 2020
    Format:
    Podcast episode

    Description

    Hematology-Oncology news: Chemo-free management of mesothelioma on horizon: https://bit.ly/2CyL6xY CheckMate 743: https://bit.ly/2CBy6HX INITIATE trial: https://bit.ly/3axxdg8 MAPS2: https://bit.ly/32hWCa0 FDA approves first liquid biopsy/NGS test for lung cancer: https://bit.ly/3258jRn Swallowable 'sponge on a string' to diagnose esophageal cancer: https://bit.ly/3iUbLFb Source: https://bit.ly/2Q0T6en COVID-19 impact: Less chemo, immune checkpoint inhibitors, and steroids: https://bit.ly/2Ebwmpq Survey: https://bit.ly/3h14S4h Email Blood & Cancer: podcasts@mdedge.com    
    Released:
    Aug 18, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    The official podcast feed of MDedge Hematology-Oncology, part of the Medscape Professional Network. On Thursdays, Dr. David Henry interviews key opinion leaders and rising stars in hematology and oncology. The information in this podcast is provided for informational and educational purposes only.